EHA 2014: Meeting Highlights in Hodgkin Lymphoma

Dr. Hutchings provides an overview of the recent revisions to the ESMO guidelines for the treatment and management of Hodgkin lymphoma as well as future challenges in the management of this disease.
Dr. Borchmann reports on the targeted BEACOPP study by the German Hodgkin Lymphoma Study Group as first-line treatment of advanced stage Hodgkin lymphoma.
Dr. Pavlovsky shares the interim analysis of the PET-CT adapted therapy after 3 cycles of ABVD for all stages of Hodgkin lymphoma.
Dr. Engert discusses treatment of patients with Hodgkin lymphoma, diagnostics, and follow-up, including the risk of secondary malignancies in the future.
Dr. Johnson reports on the role of PET scanning in the management of Hodgkin lymphoma and the relationship to traditional clinical prognostic factors.
Dr. Björkholm discusses the background of Hodgkin lymphoma treatment over the last 50 years, trends in survival and the effect of better management on the outcomes of this disease.

Results 1 - 6 of 6

MediCom Worldwide, Inc. would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support. To better serve the needs of our audience, is now

©2020 MediCom Worldwide, Inc. All rights reserved